Form4insider filings, from the source

Insider holders · CIK 0001516479

Insys Therapeutics, Inc. · INSY

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Michael L BabichPresident and CEO421,572—421,572Sep 22, 2015 · 6:36 pm EDTForm 4
JOHN N KAPOOR TRUST DATED SEPTEMBER 20 198910% Owner31,98256,28888,270Mar 1, 2018 · 6:00 pm ESTForm 4
John N KapoorDirector31,98256,28888,270Mar 1, 2018 · 6:00 pm ESTForm 4
Patrick FourteauDirector69,682—69,682Aug 4, 2017 · 5:33 pm EDTForm 4
Steven J MeyerDirector56,083—56,083May 10, 2018 · 2:53 pm EDTForm 4
Saeed MotahariPresident & CEO26,400—26,400Apr 17, 2018 · 2:27 pm EDTForm 4
Darryl S BakerChief Financial Officer18,312—18,312Jan 17, 2017 · 7:12 pm ESTForm 5
Mark E NanceChief Legal Officer & Gen Cnsl15,000—15,000Oct 12, 2018 · 4:43 pm EDTForm 4
Theodore H StanleyDirector2,00010,20012,200Aug 16, 2016 · 8:23 pm EDTForm 4
Rohit VishnoiDirector10,000—10,000May 10, 2018 · 2:55 pm EDTForm 4
Pierre LapalmeDirector6,0001,0007,000May 10, 2018 · 2:54 pm EDTForm 4
Elizabeth BohlenDirector6,000—6,000Aug 9, 2018 · 4:13 pm EDTForm 4
Andrew G LongChief Financial Officer5,000—5,000Aug 7, 2018 · 3:10 pm EDTForm 4
Santosh VetticadenInterim CEO1,428—1,428Jan 17, 2017 · 10:37 am ESTForm 3
Daniel BrennanExec VP & Chf Operations Off.1—1Aug 9, 2016 · 7:12 pm EDTForm 4
Franc Del FosseGeneral Counsel0—0Jun 10, 2015 · 5:56 pm EDTForm 4
Brian TambiDirector0—0May 14, 2018 · 5:50 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.